In the post-pandemic period, the Zacks Medical - Outpatient and Home Healthcare industry has been witnessing a rapid shift toward digital healthcare treatment. In the past few years, there has been a significant rise in demand for telemedicine-focused online medical and artificial intelligence (AI)-powered technology services. Post-pandemic, many healthcare companies that were traditionally not technology-based transformed to survive in the market. Per a report by Precedence Research, the global home health ...

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. DaVita HealthCare (DVA) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question.DaVita HealthCare is one of 1050 individual stocks in the Medical sector. Collectively, these ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.It also includes access to the Zacks Style Scores.What are the Zacks Style Scores?The Zacks Style Sco ...

DaVita Inc. (NYSE:DVA) Q1 2024 Earnings Conference Call May 2, 2024 5:00 PM ET Company Participants Nic Eliason - Group Vice President, Investor Relations Javier Rodriguez - Chief Executive Officer Joel Ackerman - Chief Financial Officer Conference Call Participants Andrew Mok - Barclays Pito Chickering - Deutsche Bank Kevin Fischbeck - Bank of America Dean Rosales - Wolfe Research Gary Taylor - Cowen A.J. Rice - UBS Lisa Clive - Bernstein Operator Good evening. My name is Michelle, and I will be your confe ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ___________ Commission File Number: 1-14106 DAVITA INC. Delaware 51-0354549 (State of incorporation) (I.R.S. Employer Identification No.) 2000 16th Street ...

Contact: Investor Relations DaVita Inc. ir@davita.com DaVita Inc. 1st Quarter 2024 Results Volume: Total U.S. dialysis treatments for the first quarter of 2024 were 7,151,512, or an average of 92,159 treatments per day, representing a per day decrease of (0.4)% compared to the fourth quarter of 2023. Normalized non-acquired treatment growth in the first quarter of 2024 compared to the first quarter of 2023 was 0.4%. Denver, Colorado, May 2, 2024 — DaVita Inc. (NYSE: DVA) announced financial and operating re ...

DaVita Inc. (DVA) is scheduled to release first-quarter 2024 results on May 2, after the closing bell.In the last reported quarter, the company’s earnings per share (EPS) of $1.87 surpassed the Zacks Consensus Estimate by 22.2%. Over the trailing four quarters, its earnings outperformed the Zacks Consensus Estimate on all occasions, delivering an earnings surprise of 35.6%, on average.Let’s see how things have shaped up prior to this announcement.Factors at PlayOn fourth-quarter 2023 earnings call in Februa ...

Finding firms with strong growth potential is essential for healthcare investors looking for large profits. Three exceptional firms have surfaced as strong healthcare stocks. Each exhibits unique approaches and accomplishments in biotechnology, healthcare services, and pharmaceuticals. Solid product leads, especially in the U.S. market, have propelled the first company’s biosimilar industry to an astounding rise. This company’s dedication to prudent money management and wise investments puts it in a positio ...

These high-flying Buffett stocks could be attractive to different kinds of investors.Warren Buffett is doing it again. Berkshire Hathaway has trounced the returns of the S&P 500 index since Buffett took control of the company in 1965. Buffett continues to beat the market this year with Berkshire's shares up two times higher than that of the S&P.Some of Berkshire's strong gains can be attributed to high-flying stocks in its investment portfolio. Here are Buffett's three best-performing stocks so far in 2024. ...

DaVita HealthCare (DVA) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.Over the past month, shares of this kidney dialysis provider have returned -1.7%, compared to the Zacks S&P 500 composite's -4.2% change. During this period, the Zacks Medical - Outpatient and Home Healthcare industry, which DaVita HealthCare falls in, has lost 4.4%. The key question now is: Wh ...